P. J. Blankestijn

406 total citations
16 papers, 253 citations indexed

About

P. J. Blankestijn is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Epidemiology. According to data from OpenAlex, P. J. Blankestijn has authored 16 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 3 papers in Nephrology and 3 papers in Epidemiology. Recurrent topics in P. J. Blankestijn's work include Blood Pressure and Hypertension Studies (7 papers), Heart Rate Variability and Autonomic Control (4 papers) and Cardiac, Anesthesia and Surgical Outcomes (3 papers). P. J. Blankestijn is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Heart Rate Variability and Autonomic Control (4 papers) and Cardiac, Anesthesia and Surgical Outcomes (3 papers). P. J. Blankestijn collaborates with scholars based in Netherlands, United States and Poland. P. J. Blankestijn's co-authors include Ton J. Rabelink, Pieter F. Vos, H J van Rijn, Hailey J. Jansen, F. T. J. Boereboom, H. A. Koomans, P. Liam Oey, Willem P.Th.M. Mali, Heinz Rupp and B.C. Eikelboom and has published in prestigious journals such as Journal of the American Society of Nephrology, The Annals of Thoracic Surgery and Nephrology Dialysis Transplantation.

In The Last Decade

P. J. Blankestijn

14 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. J. Blankestijn Netherlands 8 115 92 81 78 75 16 253
Inna Kolesnyk Netherlands 7 269 2.3× 102 1.1× 46 0.6× 51 0.7× 69 0.9× 9 303
Marı́a-de-Jesús Ventura Mexico 7 242 2.1× 62 0.7× 43 0.5× 56 0.7× 104 1.4× 10 296
Michael Pappas Greece 7 222 1.9× 129 1.4× 28 0.3× 75 1.0× 92 1.2× 9 331
Sung Ro Yun South Korea 5 227 2.0× 75 0.8× 24 0.3× 36 0.5× 101 1.3× 10 286
G. Ciao Italy 5 271 2.4× 104 1.1× 111 1.4× 30 0.4× 79 1.1× 5 296
Paolo Pasini Italy 5 282 2.5× 88 1.0× 170 2.1× 42 0.5× 88 1.2× 7 336
Tony Elias Australia 5 266 2.3× 143 1.6× 21 0.3× 54 0.7× 105 1.4× 10 315
Franca Pasticci Italy 6 284 2.5× 89 1.0× 166 2.0× 42 0.5× 85 1.1× 7 344
Luca Gabutti Switzerland 9 235 2.0× 38 0.4× 45 0.6× 50 0.6× 73 1.0× 13 313
Jason A. Chou United States 9 319 2.8× 89 1.0× 105 1.3× 43 0.6× 173 2.3× 10 405

Countries citing papers authored by P. J. Blankestijn

Since Specialization
Citations

This map shows the geographic impact of P. J. Blankestijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. J. Blankestijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. J. Blankestijn more than expected).

Fields of papers citing papers by P. J. Blankestijn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. J. Blankestijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. J. Blankestijn. The network helps show where P. J. Blankestijn may publish in the future.

Co-authorship network of co-authors of P. J. Blankestijn

This figure shows the co-authorship network connecting the top 25 collaborators of P. J. Blankestijn. A scholar is included among the top collaborators of P. J. Blankestijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. J. Blankestijn. P. J. Blankestijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sanders, Margreet F., Ronald Jäger, Michiel L. Bots, Melvin D. Lobo, & P. J. Blankestijn. (2016). [OP.7D.03] RENAL DENERVATION IN HYPERTENSIVE PATIENTS NOT ON BLOOD PRESSURE LOWERING DRUGS. Journal of Hypertension. 34(Supplement 2). e94–e95. 1 indexed citations
2.
Schelven, Leonard J. van, et al.. (2014). The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients. International Journal of Cardiology. 176(1). 8–12. 23 indexed citations
3.
Zuilen, Arjan D. van, P. J. Blankestijn, Marjolijn van Buren, et al.. (2012). Nurse practitioners improve quality of care in chronic kidney disease: two-year results of a randomised study.. PubMed. 69(11). 517–26. 21 indexed citations
4.
Blankestijn, P. J., et al.. (2012). Novel invasive strategies in antihypertensive treatment - Renal sympathetic denervation, baroreflex stimulation. Nephrology Dialysis Transplantation. 27(suppl 2). ii38–ii38. 1 indexed citations
5.
Zuilen, Arjan D. van, P. J. Blankestijn, Marjolijn van Buren, et al.. (2011). Hospital specific factors affect quality of blood pressure treatment in chronic kidney disease.. PubMed. 69(5). 229–36. 5 indexed citations
6.
Huijbregts, H.J.T.A.M., Gert J. de Borst, Wouter B. Veldhuis, et al.. (2010). Cryoplasty of the Venous Anastomosis for Prevention of Intimal Hyperplasia in a Validated Porcine Arteriovenous Graft Model. European Journal of Vascular and Endovascular Surgery. 39(5). 620–626. 11 indexed citations
7.
Prakken, Niek H. J., B.K. Velthuis, Maarten-Jan Cramer, et al.. (2010). Sympathetic activity in chronic kidney disease patients is related to left ventricular mass despite antihypertensive treatment. Nephrology Dialysis Transplantation. 25(10). 3272–3277. 31 indexed citations
8.
Oey, P. Liam, et al.. (2010). ALISKIREN REDUCES SYMPATHETIC NERVE ACTIVITY IN CHRONIC KIDNEY DISEASE PATIENTS: PP.24.467. Journal of Hypertension. 28. e386–e386. 1 indexed citations
9.
Blankestijn, P. J. & Heinz Rupp. (2008). Clinical Profile of Eprosartan: A Different Angiotensin II Receptor Blocker. Cardiovascular & Hematological Agents in Medicinal Chemistry. 6(4). 253–257. 16 indexed citations
10.
Blankestijn, P. J.. (2006). Effects of Eprosartan in Chronic Kidney Disease. Journal of clinical and basic cardiology. 8(1). 15–17. 4 indexed citations
11.
Penne, E. Lars, P. J. Blankestijn, Michiel L. Bots, et al.. (2006). [New study evaluating online haemodiafiltration for the reduction of cardiovascular morbidity and mortality in patients undergoing chronic haemodialysis].. PubMed. 150(28). 1583–5. 2 indexed citations
12.
Tobe, Takashi, et al.. (2002). The effect of on- and off-pump coronary artery bypass grafting on serum creatinine concentration. The Annals of Thoracic Surgery. 73(1). S370–S370.
13.
Blankestijn, P. J.. (1999). How to identify the haemodialysis access at risk of thrombosis? Are flow measurements the answer?. Nephrology Dialysis Transplantation. 14(5). 1068–1071. 21 indexed citations
14.
Boereboom, F. T. J., Chris J.G. Bakker, Willem P.Th.M. Mali, et al.. (1996). Access flow measurements in hemodialysis patients. Journal of the American Society of Nephrology. 7(6). 966–969. 57 indexed citations
15.
Blankestijn, P. J., et al.. (1995). High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients.. Journal of the American Society of Nephrology. 5(9). 1703–1708. 58 indexed citations
16.
Blankestijn, P. J., Anton H. van den Meiracker, A. J. Man inʼt Veld, et al.. (1991). Nebivolol. Clinical Drug Investigation. 3(S1). 152–154. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026